Rufinamide vs placebo
Vomiting · people with drug‐resistant focal epilepsy
Rufinamide may leads to higher adverse effects: vomiting compared with placebo (low certainty).
1 finding from 1 review
- RR 2.95 [1.8, 4.82]4 studies · 777 participantsLow
Rufinamide may leads to higher adverse effects: vomiting compared with placebo (low certainty).